SWTX-143 | TEAD inhibitor | Probechem Biochemicals

Chemical Structure : SWTX-143

加入收藏

SWTX-143 (SWTX143)

货号: PC-21317Not For Human Use, Lab Use Only.

SWTX-143 is a potent, irreversible and covalent YAP/TAZ-TEAD inhibitor with IC50 of 12 nM in luciferase reporter assays, binds to the palmitoylation pocket of all four TEAD isoforms, inhibits Hippo pathway-mutant cancer cells.

规格	价格	库存	数量
50 mg		Get quote
100 mg		Get quote
200 mg		Get quote
1 g		Get quote

获取报价单

* 请选择数量再加入购物车

or Bulk Inquiry

大包装，大折扣！

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

生物&药学活性

SWTX-143 is a potent, irreversible and covalent YAP/TAZ-TEAD inhibitor with IC50 of 12 nM in luciferase reporter assays, binds to the palmitoylation pocket of all four TEAD isoforms, inhibits Hippo pathway-mutant cancer cells.

SWTX-143 potently represses luciferase expression from the TEAD reporter (IC50=12 nmol/L) while not affecting the viability of HEK293 cells.

SWTX-143 is sufficient to evoke a long-lasting transcriptional impact.

SWTX-143 inhibits the proliferation of Hippo pathway-mutant cancer cell lines with IC50 of 5-207 nM against three distinct desothelioma cancer cell lines that are characterized by and depend on loss-of-function alterations in NF2 (Mero-14, NCI-H226, and CI-H2052) and one that is deficient in ATS1 and LATS2 (MSTO-211H).

SWTX-143 only modestly impacts the proliferation of the NCI-H28 and NCI-H2452 mesothelioma, HeLa, SiHa, and CaSki cancer cell lines which lack genetic alterations in known Hippo pathway components (Hippo-WT).

SWTX-143 (10, 25, and 50 mg/kg) causes regression of NF2-deficient human mesothelioma xenografts.

SWTX-143 also selectively impairs the growth of NF2-mutant kidney cancer cell lines, blocks Hippo pathway transcriptional output and causes tumor regression in preclinical mesothelioma models.

物理化学性质&存储条件

分子量	361.37
分子式	C19H18F3N3O
外观性状	Solid
CAS No.
储存条件	固体粉末 -20°C 12 个月; 4°C 6 个月	配置液 -80°C 6 个月; -20°C 6 个月
Shipping
Solubility	10 mM in DMSO
Chemical Name/SMILES	N-[5-Amino-1,2,3,4-tetrahydro-1-[4-(trifluoromethyl)phenyl]-3-quinolinyl]-2-propenamide

参考文献

1. Hanne Hillen, et al. Mol Cancer Ther. 2023 Sep 23. doi: 10.1158/1535-7163.MCT-22-0681.

SWTX-143 (SWTX143)

生物&药学活性

物理化学性质&存储条件

参考文献

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

询单

SWTX-143 (SWTX143)

生物&药学活性

物理化学性质&存储条件

参考文献

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

询单

Get Quotation Now

* Indicates a Required FieldYour information is safe with us.